Vireo Growth Inc. 10-Q

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds No unregistered sales of equity securities occurred during the nine months ended September 30, 2023. ​ Item 6. Exhibits ​ Exhibit No. Description of Exhibit ​ 10.47 ​ ​ Options Agreement dated as of August 11, 2023, by and among Vireo Health, Inc., HA-MD LLC, and certain other parties specified therein. ​ 10.48 ​ First Amendment to the Consulting Agreement, dated September 20, 2023, by and between Goodness Growth Holdings, Inc. and Grown Rogue Unlimited, LLC. ​ 10.49 ​ Separation Agreement dated September 21, 2023, between Vireo Health, Inc., and John Heller. ​ ​ ​ 31.1 ​ Rule 13a-14(a)/15d-14(a) certification of Chief Executive Officer ​ 32.1 ​ Section 1350 certification, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 ​ 101 ​ Includes the following financial and related information from Goodness Growth’s Quarterly Report on Form 10-Q as of and for the quarter ended September 30, 2023, formatted in Inline Extensible Business Reporting Language (iXBRL): (1) the Consolidated Balance Sheets, (2) the Consolidated Statements of Income, (3) the Consolidated Statements of Comprehensive Income, (4) the Consolidated Statements of Changes in Stockholders’ Equity, (5) the Consolidated Statements of Cash Flows, and (6) Notes to Consolidated Financial Statements. ​ ​ ​ 104 ​ The cover page from this Quarterly Report on Form 10-Q, formatted in Inline XBRL. ​ ​ ​ ​ ​ 34 SIGNATURES Pursuant to requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. ​ ​ GOODNESS GROWTH HOLDINGS, INC. (Registrant) ​ ​ ​ Date: November 14, 2023 By: /s/ Joshua Rosen ​ ​ Name: Joshua Rosen ​ ​ Title: Interim Chief Executive Officer ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 35